** Shares of Divi's Laboratories DIVI.NS fall as much as
3% to 3,401.1 rupees, steepest intraday fall since Sept. 28
** The pharmaceutical co reported on Monday its consolidated
profit fell 29.4% to 3.48 bln rupees ($41.81 million) and missed
analysts' estimate of 4.41 billion rupees, as per LSEG data
** Co's margin dragged by higher expenses despite easing
price pressures in U.S. markets
** DIVI trading below its 50-day and 100-day simple moving
averages since mid October
** Mean rating of 21 analysts covering the stock is "sell";
median PT is 3,030 rupees - LSEG data
** Stock currently down 1.6% trimming YTD gains to 1.1%
($1 = 83.2425 Indian rupees)
(Reporting by Ashna Teresa Britto in Bengaluru)
((AshnaTeresa.Britto@thomsonreuters.com ; ( +91 8078332441))